Blog
RSS FeedPosted by Michael Wonder on 13 Aug 2017
Breast cancer sufferer Claire McLintock fundraising for new drug palbociclib
12 August 2017 - Claire McLintock knows she will eventually die of cancer. ...
Posted by Michael Wonder on 25 Jul 2017
Daughters' fight to save father's life
25 July 2017 - When Maria and Loren Calder found out their father had lung cancer, they didn't think they ...
Posted by Michael Wonder on 01 Jul 2017
New Zealand Pharmaceutical Schedule - 1 July 2017
1 July 2017 - The July 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 15 Jun 2017
Cancer patients, children, and people with HIV amongst those to benefit from PHARMAC decisions
15 June 2017 - PHARMAC has announced the funding of five new treatments and wider use of over 30 existing ...
Posted by Michael Wonder on 15 Jun 2017
Bendamustine funding approved
15 June 2017 - PHARMAC is pleased to announce the approval of an agreement with Janssen-Cilag for the listing of ...
Posted by Michael Wonder on 13 Jun 2017
Decision relating to various oncology medicines
13 June 2017 - PHARMAC is pleased to announce the approval of proposals for various oncology pharmaceuticals, including new listings ...
Posted by Michael Wonder on 30 May 2017
National MP urges PHARMAC to consider 'gold standard' neuroendocrine cancer treatment
30 May 2017 - A National MP and chair of Parliament's health committee says it's important PHARMAC consider funding a ...
Posted by Michael Wonder on 25 May 2017
New medicines funding for breast cancer still elusive
25 May 2017 - The Breast Cancer Aotearoa Coalition (BCAC) welcomes new funding for the Government’s drug-buying agency, PHARMAC, but ...
Posted by Michael Wonder on 23 May 2017
Neuroendocrine cancer sufferers take on PHARMAC
20 May 2017 - Jess Spence hurried in from the rain having just finished yoga class. ...
Posted by Michael Wonder on 15 May 2017
Proposal to list bendamustine hydrochloride
15 May 2017 - PHARMAC is seeking feedback on a proposal to list bendamustine hydrochloride (Ribomustin) through a provisional agreement ...
Posted by Michael Wonder on 08 May 2017
Southern Cross launches cover for cancer drugs not funded by PHARMAC
8 May 2017 - The frightening cost of non-PHARMAC funded cancer treatments has prompted the country's largest health insurer to ...
Posted by Michael Wonder on 08 May 2017
Proposal for various oncology medicines
8 May 2017 - PHARMAC is seeking feedback on a proposal for various oncology pharmaceuticals, including new listings and amendments ...
Posted by Michael Wonder on 29 Apr 2017
Decision to list 5-aminolevulinic acid hydrochloride (Gliolan) on the Hospital Medicines List
28 April 2017 - PHARMAC is pleased to announce that the approval of an agreement with Specialised Therapeutics Limited for ...
Posted by Michael Wonder on 26 Apr 2017
Lung cancer patients call for funded Keytruda
25 April 2017 - Patients with lung cancer say they urgently need better-funded treatments for the disease, including Keytruda. ...
Posted by Michael Wonder on 19 Apr 2017
Cancer patients want New Zealand funded treatment
20 April 2017 - Patients with a little-known cancer want a new treatment funded in this country, so they don't have ...